Latest News – 12 September 2025

International Work

WHO Collaborating Centre for Standardization and Evaluation of Vaccines Re-Designated by WHO

WHO Collaborating Centre for Quality Assurance of Blood Products and in vitro Diagnostic Devices (IVD) Designated for Sixth Time

Press Releases

Federal Minister of Health Nina Warken visits Paul-Ehrlich-Institut – Biomedicine as Key to Modern Healthcare and German Innovation

Animal Model Shows: COVID-19 Vaccines Protect Without Disease-Enhancing Effects (VAERD)

Comparison of Flu Viruses: Why Some Influenza Viruses Are More Dangerous Than Others

Clinical Trials

CDx Performance Studies Conducted in Parallel with Clinical Trials: COMBINE Programme Aims to Reduce Administrative Burden and Accelerate Access to Innovative Treatment Concepts

#VaccineFacts

#VaccineFacts Continue Their Impact: The Paul-Ehrlich-Institut Provides Vaccine Information – Even Beyond the Digital Awareness Campaign

Blood and Plasma Donor Questionnaire

Elimination of the exclusion criteria after residence in the United Kingdom

Medicine Safety

Pharmacovigilance Report on the Use of COVID-19 Vaccines – Status as of 31 December 2024

FAQ: What should be taken into account when using public data on reports of suspected adverse events?

International Work

CHMP Meeting Highlights July 2025

PRAC Meeting Highlights June 2025

Information on the Topic of Vaccination Damages

The Paul-Ehrlich-Institut is not responsible for processing applications for recognition of vaccine damages.

The Paul-Ehrlich-Institut does not have any information, figures/data on vaccine damage procedures.

Recognition procedures for vaccination damages in accordance with section 24 of the Social Code (Sozialgesetzbuch, SGB) XIV are handled exclusively by the Social Welfare Office in the federal state in whose territory the vaccination was carried out. Sections 4, 5 and 113 of the SGB XIV provide information on the competent authority, compensation for official measures and payment obligations.

Important Short Links for Your Research

• Da­ta on suspected Ad­verse Drug Re­ac­tions
  www.pei.de/adr-data
• COVID-19 safety reports:
  www.pei.de/safety-covid-19-vaccines
• COVID-19 vaccines (with link to product information):
  www.pei.de/covid-19-vaccines
• Corona FAQ (including approval and development, efficacy and safety, batch testing and antigen testing):
  www.pei.de/faq-coronavirus-en
• Explainer videos as well as recordings of press briefings:
  www.youtube.com/channel/UC0GDU8v6JtuozYQqfjJN8bg/videos

top